NeurAxis, Inc. (NRXS) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Biotechnologie Branche. Der Hauptsitz des Unternehmens ist in Carmel, IN, United States. Der aktuelle CEO ist Brian Carrico.
NRXS hat IPO-Datum 2023-08-09, 21 Vollzeitbeschäftigte, gelistet an der American Stock Excha, eine Marktkapitalisierung von $78.31M.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
